LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.56 | 21.74 | 15 | 4838 | 0.0031 | -0.0465 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 49.56 | 21.74 | 2388 | 4838 | 0.4935 | 0.8268 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.53 | 21.74 | 189 | 5150 | 0.0367 | 0.3154 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.53 | 21.74 | 2724 | 5150 | 0.5289 | 0.8448 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.53 | 21.74 | 27 | 5150 | 0.0052 | 0.0279 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 51.53 | 21.74 | 2559 | 5150 | 0.4968 | 0.8303 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.50 | 21.74 | 203 | 5425 | 0.0374 | 0.3239 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.50 | 21.74 | 2912 | 5425 | 0.5367 | 0.8497 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.50 | 21.74 | 29 | 5425 | 0.0053 | 0.0368 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 53.50 | 21.74 | 2739 | 5425 | 0.5048 | 0.8355 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 21.74 | 192 | 5768 | 0.0333 | 0.3107 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 21.74 | 3072 | 5768 | 0.5325 | 0.8495 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 21.74 | 33 | 5768 | 0.0057 | 0.0532 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 55.48 | 21.74 | 2898 | 5768 | 0.5024 | 0.8361 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.45 | 21.74 | 246 | 6023 | 0.0408 | 0.3485 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.45 | 21.74 | 3273 | 6023 | 0.5434 | 0.8552 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.45 | 21.74 | 46 | 6023 | 0.0076 | 0.0968 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 57.45 | 21.74 | 3054 | 6023 | 0.5070 | 0.8394 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.42 | 21.74 | 279 | 6125 | 0.0455 | 0.3683 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.42 | 21.74 | 3424 | 6125 | 0.5590 | 0.8621 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.42 | 21.74 | 44 | 6125 | 0.0072 | 0.0905 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 59.42 | 21.74 | 3197 | 6125 | 0.5219 | 0.8464 | MN20160310_N01 | L15 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.39 | 21.74 | 359 | 6112 | 0.0587 | 0.4116 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.39 | 21.74 | 3608 | 6112 | 0.5902 | 0.8745 | MN20160310_N01 | J22 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.56234 | 62.39 | 21.74 | 46 | 6112 | 0.0075 | 0.0965 | MN20160310_N01 | L15 |